Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)
ClinicalTrials.gov study NCT04755244. IPD Sharing: NO. Countries: 1. Publications: 1.
Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)
ClinicalTrials.gov study NCT04326023. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00006265. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00101231. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bexarotene in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00316030. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04746235. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00017589. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00005823. IPD Sharing: Not stated. Countries: 1. Publications: 3.
CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04351022. IPD Sharing: NO. Countries: 1. Publications: 2.
Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00703300. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01382147. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00850382. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia
ClinicalTrials.gov study NCT04938115. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02864290. IPD Sharing: NO. Countries: 2. Publications: 1.
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04402541. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
ClinicalTrials.gov study NCT00903422. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03862157. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00283114. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06399640. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Natural Killer-cell Therapy for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04347616. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.